I think in Canada it's not just about having the best health care, but it's about having the best health care equitably delivered. It has to be equitable within provinces as much as possible, and between provinces as well. In terms of drug approval, Health Canada controls that process. I would think of calling brainstorming sessions with Health Canada and the drug approval teams within Health Canada to start looking at this particular issue, because it is going to take some outside-the-box solutions. But there are people who are working on ideas and they will be well known to the decision-makers within Health Canada.
If we can move forward with this, then Canada will be in the vanguard of more individualized approaches to cancer and other treatments. If we can't, then we will fall behind, which would be very tragic considering that a lot of the base data, which we use to make that move, would have come from Canadian researchers and Canadian government investments.